Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression
NCT02178683
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Graft Versus Host Disease
Interventions
DRUG:
Tacrolimus and MMF.
Sponsor
Colorado Blood Cancer Institute